PineBridge Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.6M Sell
61,394
-7,475
-11% -$2.66M 0.18% 113
2025
Q4
$22.5M Sell
68,869
-83,646
-55% -$26.5M 0.17% 109
2025
Q3
$43M Buy
152,515
+33,763
+28% +$9.79M 0.32% 70
2025
Q2
$33.2M Sell
118,752
-20,201
-15% -$5.72M 0.26% 88
2025
Q1
$43.3M Buy
138,953
+17,340
+14% +$5.12M 0.34% 65
2024
Q4
$31.7M Buy
121,613
+86,927
+251% +$25.8M 0.24% 91
2024
Q3
$11.2M Sell
34,686
-2,968
-8% -$971K 0.08% 209
2024
Q2
$11.8M Sell
37,654
-47,851
-56% -$14.1M 0.09% 203
2024
Q1
$24.3M Sell
85,505
-34,896
-29% -$10.2M 0.19% 121
2023
Q4
$34.7M Buy
120,401
+48,099
+67% +$13.1M 0.32% 65
2023
Q3
$19.4M Buy
72,302
+15,369
+27% +$3.84M 0.22% 118
2023
Q2
$12.6M Sell
56,933
-118,585
-68% -$27.5M 0.14% 156
2023
Q1
$42.4M Buy
175,518
+50,259
+40% +$12.3M 0.48% 48
2022
Q4
$32.9M Sell
125,259
-100,524
-45% -$26.9M 0.4% 64
2022
Q3
$50.9M Buy
225,783
+63,576
+39% +$15.4M 0.66% 27
2022
Q2
$39.5M Sell
162,207
-55,268
-25% -$13.5M 0.5% 46
2022
Q1
$52.6M Sell
217,475
-35,900
-14% -$8.25M 0.56% 34
2021
Q4
$57M Buy
253,375
+11,070
+5% +$2.34M 0.58% 32
2021
Q3
$51.5M Buy
242,305
+218,323
+910% +$50.3M 0.62% 28
2021
Q2
$5.85M Sell
23,982
-19,571
-45% -$4.81M 0.07% 297
2021
Q1
$10.8M Sell
43,553
-79,028
-64% -$18.9M 0.14% 189
2020
Q4
$28.2M Buy
122,581
+26,162
+27% +$6.03M 0.43% 48
2020
Q3
$24.5M Sell
96,419
-13,689
-12% -$3.39M 0.42% 53
2020
Q2
$26M Buy
110,108
+13,644
+14% +$3.11M 0.5% 49
2020
Q1
$19.6M Buy
96,464
+28,523
+42% +$6.23M 0.46% 48
2019
Q4
$16.4M Sell
67,941
-1,589
-2% -$350K 0.25% 105
2019
Q3
$13.5M Sell
69,530
-224,250
-76% -$43M 0.22% 123
2019
Q2
$54.1M Buy
293,780
+43,770
+18% +$7.84M 0.88% 19
2019
Q1
$47.5M Buy
250,010
+37,739
+18% +$7.21M 0.96% 15
2018
Q4
$41.3M Sell
212,271
-27,934
-12% -$5.45M 0.92% 16
2018
Q3
$49.8M Buy
240,205
+90,588
+61% +$17.9M 0.94% 15
2018
Q2
$27.6M Sell
149,617
-586
-0.4% -$104K 0.68% 24
2018
Q1
$25.6M Buy
150,203
+3,555
+2% +$653K 0.61% 28
2017
Q4
$25.5M Sell
146,648
-10,893
-7% -$1.93M 0.66% 26
2017
Q3
$29.4M Sell
157,541
-8,492
-5% -$1.5M 0.71% 26
2017
Q2
$28.6M Buy
166,033
+156,382
+1,620% +$25.4M 0.75% 27
2017
Q1
$1.58M Sell
9,651
-15,425
-62% -$2.56M 0.04% 353
2016
Q4
$3.67M Buy
25,076
+13,416
+115% +$2.02M 0.11% 174
2016
Q3
$1.95M Sell
11,660
-102,735
-90% -$17.4M 0.09% 193
2016
Q2
$17.4M Sell
114,395
-16,430
-13% -$2.55M 0.89% 26
2016
Q1
$19.6M Sell
130,825
-61,201
-32% -$9.09M 1.01% 20
2015
Q4
$31.2M Sell
192,026
-29,338
-13% -$4.61M 1.34% 10
2015
Q3
$30.6M Sell
221,364
-36,986
-14% -$5.83M 1.3% 11
2015
Q2
$39.7M Buy
258,350
+163,812
+173% +$26.2M 1.57% 8
2015
Q1
$15.1M Buy
94,538
+32,116
+51% +$5.06M 0.56% 52
2014
Q4
$9.94M Buy
62,422
+20,621
+49% +$3.21M 0.38% 80
2014
Q3
$5.87M Sell
41,801
-2,249
-5% -$294K 0.24% 122
2014
Q2
$5.21M Sell
44,050
-164,735
-79% -$19.1M 0.21% 131
2014
Q1
$25.8M Sell
208,785
-24,038
-10% -$2.92M 0.85% 18
2013
Q4
$26.6M Buy
232,823
+72,368
+45% +$8.23M 0.79% 21
2013
Q3
$18M Buy
160,455
+78,253
+95% +$8.49M 0.56% 52
2013
Q2
$8.11M Buy
+82,202
New +$8.53M 0.26% 116

Other funds holding AMGN

PineBridge Investments's AMGN Position: Q1 2026 in Review

PineBridge Investments reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $2.66M and leaving 61,394 shares worth $21.6M. The position accounts for 0.18% of the portfolio, ranked #113.

PineBridge Investments first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $57M in Q4 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • PineBridge Investments held 61,394 shares of Amgen worth $21.6M as of Q1 2026.
  • PineBridge Investments sold 7,475 Amgen shares in Q1 2026, an estimated $2.66M.
  • Amgen made up 0.18% of PineBridge Investments's portfolio in Q1 2026, its #113 holding.
  • PineBridge Investments first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • PineBridge Investments's Amgen position peaked at $57M in Q4 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.